NCT04264520

Brief Summary

The current study aims to test a brief computer-assisted intervention (psychoeducation + skills) for pregnant women with elevated PTSD symptoms. In this open trial pilot feasibility study, 20 pregnant women in their first trimester will be invited to participate in the study if they endorse elevated PTSD symptoms. Oxytocin and cortisol will be measured at baseline, one month post-intervention, three months post-intervention, and post-delivery to inform the relationship between these hormones, PTSD symptoms, and peripartum/postpartum outcomes. In addition to receiving the psychoeducation + skills intervention during their first trimester, women will be offered a "booster session" intervention following delivery to enhance utilization of skills during a critical period for maternal mental and physical health outcomes.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 3, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 11, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

June 5, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 23, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 23, 2021

Completed
Last Updated

October 24, 2024

Status Verified

October 1, 2024

Enrollment Period

11 months

First QC Date

February 3, 2020

Last Update Submit

October 22, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • PTSD Checklist for DSM-5 (PCL-5) Total Scores

    The PCL-5 is a 17-item self-report questionnaire designed to assess PTSD symptoms among civilians. In the current study, PCL-5 total scores will be utilized. Specifically, we will examine the impact of the intervention on change in PCL-5 scores across time (i.e., from baseline to post-delivery follow-up). Scores on the PCL-5 range from 0 to 80, with higher scores indicating more symptoms.

    Baseline to follow-up (follow-up will occur at one-month following the baby's birth)

  • Baby's Weight at Birth in Pounds/Ounces

    Each baby's weight (in pounds/ounces) will be derived from the online medical record following delivery. This outcome will be used to determine the relationship between maternal PTSD symptoms (as indexed by the PCL-5 total scores--above) and infant weight at birth.

    Baseline to birth of baby.

  • Total Gestation Length in Weeks

    The total gestation length, in weeks, will be derived from the online medical record following the baby's birth. This outcome will be used to determine the relationship between maternal PTSD symptoms (as indexed by the PCL-5 total scores--above) and total weeks gestation at birth.

    Baseline to birth of baby.

  • Baby's APGAR Score at Birth

    Each baby's APGAR score will be derived from the online medical record following delivery. APGAR scores range from 0-10, with higher scores indicating better health at birth for baby. APGAR scores will be used to determine the relationship between maternal PTSD symptoms (as indexed by the PCL-5 total scores--above) and infant health at birth.

    Baseline to birth of baby.

Study Arms (1)

PTSD Psychoeducation + Skills Intervention

EXPERIMENTAL
Behavioral: PTSD Psychoeducation + Skills Intervention

Interventions

A brief computer-assisted intervention (psychoeducation + skills) for pregnant women with elevated PTSD symptoms.

PTSD Psychoeducation + Skills Intervention

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsIntervention for pregnant women, so only women can be included.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years old
  • Fluent in English

You may not qualify if:

  • Active and severe domestic violence
  • Evidence of a significant mental illness or current substance use disorder that would impede the completion of the intervention
  • Suicidal individuals deemed at immediate danger or risk (i.e., requiring immediate hospitalization or treatment)
  • Women who smoke
  • Women who have a metabolic or endocrine disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina Institute of Psychiatry

Charleston, South Carolina, 29425, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticDepression, Postpartum

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersPuerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Open Label Pilot Trial (no control group)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 3, 2020

First Posted

February 11, 2020

Study Start

June 5, 2020

Primary Completion

April 23, 2021

Study Completion

April 23, 2021

Last Updated

October 24, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations